FTH compared with DBVT: revenue, margins and what each company keeps, and the suppliers and customers both name

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

DBVTDBV Technologies S.A.

Mkt capRevenueRevenue

Compare

FTHFaeth Therapeutics, Inc.

DBVTDBV Technologies S.A.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

FTH1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.73%—

DBVT1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±43.1%▼−3.38%×0.08

= impliedFTH realized, solidDBVT realized, hatchedOne scale, both sides: full bar = 44%× = |realized| ÷ impliedSource: market data

FTHFaeth Therapeutics, Inc.

19.07▲+2.06%

Mkt cap$483.0MRevenue—Revenue—

DBVTDBV Technologies S.A.

9.12▼−3.90%

Regular sessionNov 2 '26

Mkt cap$596.7MRevenue$2MQ3 FY26Revenue$6MFY25

Compare

Regular sessionNov 2 '26

FTHFaeth Therapeutics, Inc.

DBVTDBV Technologies S.A.

19.07▲+2.06%

Price

9.12▼−3.90%

$483.0M

Mkt cap

$596.7M

—

Revenue

$2MQ3 FY26

—

Revenue

$6MFY25

FTH19.07▲+2.06%vsDBVT9.12▼−3.90%Regular sessionNov 2 '26